![](/img/cover-not-exists.png)
P-795 Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC)
Smit, E., Groen, H., Biesma, B., vd Wilt, C., Koolen, M., de Jong, W., van Tinteren, H., van Bochove, A.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81288-7
Date:
July, 2005
File:
PDF, 132 KB
english, 2005